COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 1559: Articles 15581-15590  | Next

Short time effect of Covid 19 pandemic on HbA1c and acute metabolic complications in children with type 1 diabetes
Arslanoglu, I., Akcali, F., Yavuzyilmaz, F., Sungur, M. A.
10.1101/2021.04.18.21255687 — Posted: 2021-04-22
A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results
Cleary, J. L., Fang, Y., Sen, S., Wu, Z.
10.1101/2021.04.17.21255513 — Posted: 2021-04-22
Estimating SARS-CoV-2 reproduction number by infection location in Japan
Kurita, J., Hata, T., Sugawara, T., Ohkusa, Y., Hata, A.
10.1101/2021.04.13.21255296 — Posted: 2021-04-22
MARCH8 targets cytoplasmic lysine residues of various viral envelope glycoproteins
Zhang, Y., Ozono, S., Tada, T., Tobiume, M., Kameoka, M., Kishigami, S., Fujita, H., Tokunaga, K.
10.1101/2021.04.20.440588 — Posted: 2021-04-21
FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling
Zhou, D., Park, J.-G., Wu, Z., Huang, H., Fiches, G. N., Biswas, A., Li, T.-W., Ma, Q., Martinez-Sobrido, L., Santoso, N., Zhu, J.
10.1101/2021.04.21.440833 — Posted: 2021-04-21
Human Taste Cells Express ACE2: A Portal for SARS-CoV-2 Infection
Doyle, M., Appleton, A., Liu, Q.-R., Yao, Q., Mazucanti, C. H., Egan, J. M.
10.1101/2021.04.21.440680 — Posted: 2021-04-21
Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19
Perlman, S., Wong, L. Y. R., Zheng, J., Wilhelmsen, K., Li, K., Ortiz Bezara, M. E., Schnicker, N. J., Pezzulo, A. A. A., Szachowicz, P. J., Klumpp, K., Aswad, F., Rebo, J., Narumiya, S., Murakami, M., Meyerholz, D., Fortney, K., McCray, P. B.
10.1101/2021.04.20.440676 — Posted: 2021-04-21
Rapid and Efficient Inactivation of SARS-CoV-2 from Surfaces using UVC Light Emitting Diode Device
Dwivedi, V., Park, J.-G., Grenon, S., Medendorp, N., Hallam, C., Torrelles, J. B., Martinez-Sobrido, L., Kulkarni, V.
10.1101/2021.04.20.440654 — Posted: 2021-04-21
Characterization of the Second Wave of COVID-19 in India
Ranjan, R., Sharma, A., Verma, M. K.
10.1101/2021.04.17.21255665 — Posted: 2021-04-21
Higher COVID-19 Vaccination Rates among Unemployed in the United States: State Level Study in the First 100 days of Vaccine Initiation
Roghani, A., Panahi, S.
10.1101/2021.04.17.21255668 — Posted: 2021-04-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).